Increased levels of plasma or urine TNFα [14, 15] and elevated urinary excretion of soluble TNFα Receptor I and plasma concentrations of soluble TNFα Receptors I and II were reported in FSGS patients [16, 17]. Here, TNF is linked to focal segmental glomerulosclerosis.